The University of Chicago Header Logo

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.

BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience. J Thorac Oncol. 2019 03; 14(3):e57-e59.

View in: PubMed